Net Cash Provided by (Used in) Operating Activities |
70M |
USD |
-93.5% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
18.3B |
USD |
+59.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-16.4B |
USD |
-191% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
90B |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
566M |
shares |
-0.31% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.03B |
USD |
-70.9% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.6B |
USD |
+22.2% |
Q3 2024 |
Q3 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
167M |
USD |
-1.18% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
33M |
USD |
-68.6% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
10.5B |
USD |
+216% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Issued |
28.7M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
19M |
USD |
+26.7% |
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
15.1B |
USD |
+3.2% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
28.7M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
238M |
USD |
+44.2% |
Q1 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
1.06B |
USD |
+92.9% |
Q3 2024 |
Q3 2024 |